Sucampo Pharmaceuticals, Inc.
SCMP
SCMP was delisted on the 12th of February, 2018.
165 hedge funds and large institutions have $340M invested in Sucampo Pharmaceuticals, Inc. in 2016 Q4 according to their latest regulatory filings, with 55 funds opening new positions, 54 increasing their positions, 43 reducing their positions, and 8 closing their positions.
588% more first-time investments, than exits
New positions opened: 55 | Existing positions closed: 8
48% more capital invested
Capital invested by funds: $229M → $340M (+$111M)
39% more funds holding
Funds holding: 119 → 165 (+46)
26% more repeat investments, than reductions
Existing positions increased: 54 | Existing positions reduced: 43
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
39% less call options, than puts
Call options by funds: $1.17M | Put options by funds: $1.91M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RI
Redwood Investments
Boston,
Massachusetts
|
+$8.42M |
| 2 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$6.98M |
| 3 |
NI
Numeric Investors
Boston,
Massachusetts
|
+$6.7M |
| 4 |
Invesco
Atlanta,
Georgia
|
+$5.94M |
| 5 |
LSV Asset Management
Chicago,
Illinois
|
+$5.25M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Boston Partners
Boston,
Massachusetts
|
-$2.94M |
| 2 |
Skandinaviska Enskilda Banken (SEB)
Stockholm,
Sweden
|
-$1.69M |
| 3 |
MCM
McKinley Capital Management
Anchorage,
Alaska
|
-$1.44M |
| 4 |
Prudential Financial
Newark,
New Jersey
|
-$988K |
| 5 |
MC
Menta Capital
San Francisco,
California
|
-$842K |
SCMP Hedge Fund Activity: Q4 2016 in Review
165 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Sucampo Pharmaceuticals, Inc. (SCMP) for Q4 2016, worth a combined $340M — up 48% from $229M a quarter earlier.
Buyers outnumbered sellers: 55 funds opened new SCMP positions and 8 closed out — a net gain of 47 holders — while 54 added to existing stakes and 43 trimmed.
The largest buyer was Redwood Investments, opening a new position worth an estimated $8.42M. The largest seller was Boston Partners, exiting entirely with an estimated $2.94M sold.
- 165 institutional investors held Sucampo Pharmaceuticals, Inc. (SCMP) as of Q4 2016, up from 119 in Q3 2016.
- Funds reported $340M of Sucampo Pharmaceuticals, Inc. stock for Q4 2016, up 48% quarter-over-quarter.
- 55 funds opened new Sucampo Pharmaceuticals, Inc. positions in Q4 2016 and 8 closed out, a net change of +47 holders.
- The largest Sucampo Pharmaceuticals, Inc. buyer in Q4 2016 was Redwood Investments, an estimated $8.42M added.
- The largest Sucampo Pharmaceuticals, Inc. seller in Q4 2016 was Boston Partners, an estimated $2.94M sold.
Based on aggregated 13F filings for Q4 2016.